You have no items in your shopping cart.
Description
Research Area
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 Cells |
|---|---|
| Biological Origin | Human |
| Biological Activity | LIF Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.2 kDa and the accession number is P15018. |
| Tag | C-His |
| Expression Region | A DNA sequence encoding the human LIF (P15018) (Met1-Phe202) with a C-terminal polyhistidine tag was expressed. Predicted N terminal: Ser 23 |
| MW | 21.2 kDa (predicted); 35-42 kDa (reducing conditions) |
| Purity | 97.90% |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−gp130/IL6ST Protein, Human, Recombinant (His) [orb1960481]
98.00%
68.94 kDa (predicted). Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgSOCS1 Protein, Human, Recombinant (His) [orb1977762]
98.00%
25.6 kDa (predicted)
500 μg, 100 μg, 20 μgOncostatin M/OSM Protein, Human, Recombinant (E. coli, His) [orb1960880]
SDS-PAGE: > 99.9%; SEC-HPLC: 92.7%
10 μg, 20 μg, 50 μg, 100 μgSOCS3 Protein, Human, Recombinant (His & Trx) [orb1957473]
98.00%
41.9 kDa (predicted); 46 kDa (reducing conditions)
50 μgRecombinant Human LIF Protein, His Tag [orb1551393]
> 95% by SDS-PAGE.
Recombinant Human LIF Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Ser23-Phe202) of human LIF (Accession #NP_002300.1) fused with a 6��His Tag at the C-terminus.
100 μg, 50 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].